Varaico: Literature-Extracted Genetic Variants

Gene:HMBS
Variant:p.R195C
Back to variants list

HMBS

NM_000190.4:p.R195C

Associated Papers

A scalable approach to resolving variants of uncertain significance.

Tejura M et al.

Biorxiv : the Preprint Server for Biology, 2026

41727046 (PubMed )
Supplement: media-7.xlsx › VarChAMP_data_supp_mat_PP

Application of clinical exome sequencing in sperm donor screening in China.

Huang J et al.

Journal of Assisted Reproduction and Genetics, 2025

Estimating carrier rates and prevalence of porphyria-associated gene variants in the Chinese population based on genetic databases.

Wang Y et al.

Orphanet Journal of Rare Diseases, 2024

Systematically testing human HMBS missense variants to reveal mechanism and pathogenic variation.

van Loggerenberg W et al.

American Journal of Human Genetics, 2023

37729906 (PubMed )
Supplement: mmc2.xlsx › Enz._Activity_

Systematically testing human HMBS missense variants to reveal mechanism and pathogenic variation.

van Loggerenberg W et al.

Biorxiv : the Preprint Server for Biology, 2023

36798224 (PubMed )
Supplement: media-2.pdf

Clinical feature and genetic analysis of HMBS gene in Chinese patients with acute intermittent porphyria: a systematic review.

Ren Y et al.

Frontiers in Genetics, 2023

Clinical Challenges of Acute Porphyria in the Young Adult.

Burns S et al.

The Neurohospitalist, 2022

Identification and molecular analysis of 17 novel variants of hydroxymethylbilane synthase in Chinese patients with acute intermittent porphyria.

Hu Y et al.

Clinical Genetics, 2022

Acute Intermittent Porphyria: An Overview of Therapy Developments and Future Perspectives Focusing on Stabilisation of HMBS and Proteostasis Regulators.

Bustad HJ et al.

International Journal of Molecular Sciences, 2021

33445488 (PubMed )
Supplement: ijms-22-00675-s001.pdf

Pan-cancer whole-genome analyses of metastatic solid tumours.

Priestley P et al.

Nature, 2019

31645765 (PubMed )
Supplement: 41586_2019_1689_MOESM11_ESM.xlsx › Sheet1

Systematically Analyzing the Pathogenic Variations for Acute Intermittent Porphyria.

Fu Y et al.

Frontiers in Pharmacology, 2019

31572191 (PubMed )
Supplement: Table_2.xlsx › HMBS.vcf.hg19_multianno

From a dominant to an oligogenic model of inheritance with environmental modifiers in acute intermittent porphyria.

Lenglet H et al.

Human Molecular Genetics, 2018

Molecular characterisation of acute intermittent porphyria in a cohort of South African patients and kinetic analysis of two expressed mutants.

Fortgens P et al.

Journal of Clinical Pathology, 2017

Acute Intermittent Porphyria: Predicted Pathogenicity of HMBS Variants Indicates Extremely Low Penetrance of the Autosomal Dominant Disease.

Chen B et al.

Human Mutation, 2016

[Molecular genetic study of acute intermittent porphyria in Russia: mutation analysis and functional polymorphism search in porphobilinogen deaminase gene].

Surin VL et al.

Genetika, 2010

Novel human pathological mutations. Gene symbol: HMBS. Disease: Acute intermittent porphyria.

Ulbrichova D et al.

Human Genetics, 2010

Awareness is the name of the game: clinical and biochemical evaluation of a case of a girl diagnosed with acute intermittent porphyria associated with autism.

Luder AS et al.

Cellular and Molecular Biology (noisy-le-grand, France), 2009

Structural insight into acute intermittent porphyria.

Song G et al.

Faseb Journal : Official Publication of the Federation of American Societies for Experimental Biology, 2009

May 2006 update in porphobilinogen deaminase gene polymorphisms and mutations causing acute intermittent porphyria: comparison with the situation in Slavic population.

Hrdinka M et al.

Physiological Research, 2006

Nine mutations including three novel mutations among Russian patients with acute intermittent porphyria.

Pischik E et al.

Human Mutation, 2005

Gene-environmental interactions: Lessons from porphyria.

Sassa S

Environmental Health and Preventive Medicine, 2003

Molecular and biochemical studies of acute intermittent porphyria in 196 patients and their families.

Kauppinen R et al.

Clinical Chemistry, 2002

[Three new mutations in the porphobilinogen deaminase gene, detected in acute intermittent porphyria patients from Russia].

Surin VL et al.

Genetika, 2001

[The initial results of detecting mutations in the gene of the porphobilinogen deaminase enzyme in patients with acute intermittent porphyria in Russia].

Pivnik AV et al.

Terapevticheskii Arkhiv, 2000

Comparison of complementary and genomic DNA sequencing for the detection of mutations in the HMBS gene in British patients with acute intermittent porphyria: identification of 25 novel mutations.

Whatley SD et al.

Human Genetics, 1999

Molecular epidemiology and diagnosis of PBG deaminase gene defects in acute intermittent porphyria.

Puy H et al.

American Journal of Human Genetics, 1997

Diagnostic strategy, genetic diagnosis and identification of new mutations in intermittent porphyria by denaturing gradient gel electrophoresis.

Nissen H et al.

Human Mutation, 1997

Acute intermittent porphyria in Finland: 19 mutations in the porphobilinogen deaminase gene.

Kauppinen R et al.

Human Molecular Genetics, 1995

Correlation between biochemical findings, structural and enzymatic abnormalities in mutated HMBS identified in six Israeli families with acute intermittent porphyria.

Ulbrichova D et al.

Blood Cells, Molecules & Diseases, 0

Select a paper to view details
UCSC Genome Browser·Imprint·Privacy·Terms·Feedback·Email Updates·

Regarding the variants extracted from papers and shown text snippets from research papers, the following holds: "Some rights reserved. This work permits non-commercial use, distribution and reproduction in any medium, provided the original author and source are credited."